http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014091707-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd727aa2b4e6c347aadd94971881d671 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
| filingDate | 2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c9f22fc2fc00f755198da0ede685553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54380580ba77543f136ed065a7db51a7 |
| publicationDate | 2014-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014091707-A |
| titleOfInvention | Chronic inflammation inhibitor and cancer metastasis inhibitor |
| abstract | A novel chronic inflammation inhibitor or cancer metastasis inhibitor is provided. The present invention relates to (2R, 3R) -2-[[(E) -3- (3,4-dihydroxyphenyl) -1-oxo-2-propenyl] oxy] -3-hydroxybutanedioic acid. (Caphthalic acid), (2R, 3R) -2,3-bis {[(E) -3- (3,4-dihydroxyphenyl) prop-2-enoyl] oxy} butanedioic acid (sycoric acid), 3- (3,4-dihydroxyphenyl) propenoic acid (caffeic acid), 2- [3- (3,4-dihydroxyphenyl) acryloyloxy] succinic acid (caffeoylmalic acid) and (1S, 3R, 4S, 5R)- A chronic inflammation inhibitor or cancer metastasis inhibitor comprising one or more compounds selected from the group consisting of 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid (quinic acid) or a salt thereof, provide. [Selection] Figure 1 |
| priorityDate | 2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.